GHDX: Genomic Health, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 2,342.42
Enterprise Value ($M) 2,288.58
Book Value ($M) 225.20
Book Value / Share 6.28
Price / Book 10.40
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.02

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 5.39

Balance Sheet (mrq) ($M)
Current Assets 215.38
Assets 269.02
Liabilities 43.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 340.75
Operating Income -6.45
Net Income -3.86
Earnings Per Share Diluted -0.11
Earnings Per Share Basic -0.11
Earnings Per Share Basic And Diluted -0.11

Cash Flow Statement (mra) ($M)
Cash From Operations 30.59
Cash from Investing -42.56
Cash from Financing -42.56

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2018-03-12 13D/A Baker Brothers Advisors LP 40.40 0.01
2018-01-25 13G/A BlackRock Inc. 5.60 -17.78

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2018-08-07 10-Q GHDX / Genomic Health, Inc. 10-Q (Quarterly Report)
2018-05-09 10-Q GHDX / Genomic Health, Inc. 10-Q (Quarterly Report)
2018-03-14 10-K GHDX / Genomic Health, Inc. 10-K (Annual Report)

Source:
Fintel.io

Similar Companies
CDNA – CareDx, Inc. CGIX – Cancer Genetics, Inc.
FMI – Foundation Medicine, Inc. MGEN – Miragen Therapeutics
NTRA – Natera, Inc.


Financial data and stock pages provided for FREE by
Fintel.io